The Use of N-ethyl-urethan in Plasma Plasminogen Assay
- 1 January 1968
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 21 (2) , 182-186
- https://doi.org/10.3109/00365516809084281
Abstract
In optimal concentration, N-ethyl-urethan enhances urokinase-induced caseinolytic activity in human plasma mainly through an irreversible denaturation of inhibitors and more effectively than o-thymotic-acid-Na. In estimation of plasminogen-plasmin in human plasma, the use of N-ethyl-urethan was found to be a simpler means of denaturating inhibitors than acidification, but only partial removal of inhibitory activity was obtained. Because the presence of casein protects against the loss of proteolytic capacity in plasma, N-ethyl-urethan should be mixed with the casein and not directly with the plasma.Keywords
This publication has 7 references indexed in Scilit:
- A Family with Low Proteolytic Capacity in Plasma, Probably Related to a Low Plasminogen ContentScandinavian Journal of Clinical and Laboratory Investigation, 1966
- Animal Plasma as Substrate for Synthetic Fibrinolysis Inducers.Experimental Biology and Medicine, 1966
- Synthetic activators of fibrinolysis which possess anticoagulant propertyCellular and Molecular Life Sciences, 1965
- Venous Admixture During Exercise in Sitting PositionScandinavian Journal of Clinical and Laboratory Investigation, 1965
- The antiplasmin activity of human plasma and serum and its dependence on ionsScandinavian Journal of Clinical and Laboratory Investigation, 1964
- The caseinolytic method for determination of plasminogen-plasmin in human plasma and serumScandinavian Journal of Clinical and Laboratory Investigation, 1964
- Fibrinolysis induction in vitro by aromatic derivativesArchives of Biochemistry and Biophysics, 1962